Non-Covalent Modification of Collagen Scaffolds
胶原蛋白支架的非共价修饰
基本信息
- 批准号:7140253
- 负责人:
- 金额:$ 16.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-08-01 至 2007-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Collagen is used in a variety of medical applications ranging from hemostatic materials and biocompatible coatings to drug delivery and tissue engineering. Traditionally, collagen is used as passive (but biocompatible) materials that protect injured sites and support healing processes. Today, there is a renewed interest in collagen as bioactive scaffolds that can provide ideal environment for specific tissue formation. This has led to widespread interests in immobilizing bioactive components (such as growth factors, antimicrobial agents, or cell-repellent) to natural collagen. In this proposal we wish to investigate nonchemical immobilization of collagen mimetic peptides (CMP) and CMP derivatives on collagen scaffolds, and explore its potential as a new collagen modification technique targeted for microvasculature engineering.
Collagen mimetic peptides (CMPs) are peptides, typically of less than 30 amino acids, composed of multimers of known helicogenic trimers (e.g. ProHypGly). They have been highly useful in determining the structure and stability of natural collagens and their collagen-like triple helical structure and reversible association (melting) behaviors are documented in the literatures. In our previous studies, we discovered that CMPs can bind to collagen films (type I) under controlled thermal condition.
Main goals of this research are to further understand the CMP-collagen interaction, identify optimal CMP structure that exhibit efficient and reversible binding to collagen under physiological or near-physiological condition, and demonstrate the practical use of the poly(ethyleneglycol)-CMP conjugate in controlling the endothelial cell (ED) organization in 2D and 3D collagen scaffolds. In the long run, we wish to develop this approach into a more general collagen modification method that can provide novel solutions to complications after vascular and ocular surgery and to add therapeutic activity to conventional collagen-based biomaterials (see support letter from The Wilmer Ophthalmological Institute of the Johns Hopkins Medical School).
描述(由申请人提供):胶原蛋白用于各种医疗应用,从止血材料和生物相容性涂层到药物输送和组织工程。传统上,胶原蛋白被用作被动(但具有生物相容性)的材料,保护受伤部位并支持愈合过程。今天,人们对胶原蛋白作为生物活性支架重新产生了兴趣,它可以为特定组织的形成提供理想的环境。这引起了人们对将生物活性成分(如生长因子、抗菌剂或细胞排斥剂)固定在天然胶原蛋白上的广泛兴趣。在本研究中,我们希望研究模拟胶原肽(CMP)及其衍生物在胶原支架上的非化学固定,并探索其作为微血管工程目标的新型胶原修饰技术的潜力。
项目成果
期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
PEG-based hydrogels with collagen mimetic peptide-mediated and tunable physical cross-links.
- DOI:10.1021/bm100465q
- 发表时间:2010-09-13
- 期刊:
- 影响因子:6.2
- 作者:Stahl, Patrick J.;Romano, Nicole H.;Wirtz, Denis;Yu, S. Michael
- 通讯作者:Yu, S. Michael
Capillary Network-Like Organization of Endothelial Cells in PEGDA Scaffolds Encoded with Angiogenic Signals via Triple Helical Hybridization.
- DOI:10.1002/adfm.201303217
- 发表时间:2014-06-04
- 期刊:
- 影响因子:19
- 作者:Stahl, Patrick J.;Chan, Tania R.;Shen, Yu-I;Sun, Guoming;Gerecht, Sharon;Yu, S. M.
- 通讯作者:Yu, S. M.
Matrix-Bound VEGF Mimetic Peptides: Design and Endothelial Cell Activation in Collagen Scaffolds.
- DOI:10.1002/adfm.201101163
- 发表时间:2011-11-22
- 期刊:
- 影响因子:19
- 作者:Chan TR;Stahl PJ;Yu SM
- 通讯作者:Yu SM
Collagen Mimetic Peptides: Progress Towards Functional Applications.
- DOI:10.1039/c1sm05329a
- 发表时间:2011-09-21
- 期刊:
- 影响因子:3.4
- 作者:Yu SM;Li Y;Kim D
- 通讯作者:Kim D
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael S Yu其他文献
Michael S Yu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael S Yu', 18)}}的其他基金
Sustained Intravitreal Delivery of Ranibizumab Mediated by ECM Binding
ECM 结合介导的雷珠单抗玻璃体内持续递送
- 批准号:
9765322 - 财政年份:2018
- 资助金额:
$ 16.1万 - 项目类别:
Collagen-Targeted Therapeutics of Cathepsin Inhibitors
组织蛋白酶抑制剂的胶原蛋白靶向治疗
- 批准号:
8771219 - 财政年份:2014
- 资助金额:
$ 16.1万 - 项目类别:
Study and Application of Collagen Mimetic Peptide-Collagen Hybridization
胶原模拟肽-胶原杂交的研究及应用
- 批准号:
8664812 - 财政年份:2011
- 资助金额:
$ 16.1万 - 项目类别:
Study and Application of Collagen Mimetic Peptide-Collagen Hybridization
胶原模拟肽-胶原杂交的研究及应用
- 批准号:
8299014 - 财政年份:2011
- 资助金额:
$ 16.1万 - 项目类别:
Study and Application of Collagen Mimetic Peptide-Collagen Hybridization
胶原模拟肽-胶原杂交的研究及应用
- 批准号:
8031781 - 财政年份:2011
- 资助金额:
$ 16.1万 - 项目类别:
Study and Application of Collagen Mimetic Peptide-Collagen Hybridization
胶原模拟肽-胶原杂交的研究及应用
- 批准号:
8788304 - 财政年份:2011
- 资助金额:
$ 16.1万 - 项目类别:














{{item.name}}会员




